LICENSE AGREEMENTLicense Agreement • April 18th, 2023 • New York
Contract Type FiledApril 18th, 2023 JurisdictionThis License Agreement (this “Agreement”), dated as of April 13, 2017 (the “Effective Date”), is by and between Tikun Olam Ltd., an Israeli corporation, registration number 514263771 (“Licensor”) and TO Pharmaceuticals USA LLC, a Delaware limited liability company (“Licensee”). Licensor and Licensee shall each be individually referred to as a “Party” and collectively as the “Parties”.
EXECUTION VERSION GLOBAL PHARMA LICENSE AGREEMENTLicense Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis License Agreement (this “Agreement”), dated as of April 13, 2017 (the “Effective Date”), is by and between Tikun Olam Ltd., an Israeli corporation, registration number 514263771 (“Licensor”) and Tikun Olam IP Ltd., a Cayman Islands company (“Licensee”). Licensor and Licensee shall each be individually referred to as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENTLicense Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 12th, 2019 Company Industry JurisdictionThis License Agreement (this “Agreement”), dated as of April 13, 2017 (the “Effective Date”), is by and between Tikun Olam Ltd., an Israeli corporation, registration number 514263771 (“Licensor”) and TO Pharmaceuticals USA LLC, a Delaware limited liability company (“Licensee”). Licensor and Licensee shall each be individually referred to as a “Party” and collectively as the “Parties”.
LICENSE AGREEMENTLicense Agreement • March 12th, 2019 • AquaMed Technologies, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 12th, 2019 Company Industry JurisdictionThis License Agreement (this “Agreement”), dated as of April 13, 2017 (the “Effective Date”), is by and between Tikun Olam Ltd., an Israeli corporation, registration number 514263771 (“Licensor”) and Tikun Olam IP Ltd., a Cayman Islands company (“Licensee”). Licensor and Licensee shall each be individually referred to as a “Party” and collectively as the “Parties”.